Novartis Investigative Site

Hall in Tirol 6060

0 studies enrolling now · 2 studies all time

What they study most

Carcinoma, Renal Cell, Heart Failure With Preserved Ejection Fraction

Studies at this site

• A Randomized, Double-blind Controlled Study Comparing LCZ696 to Medical Therapy for Comorbidities in HFpEF Patients — Completed
• Observational Study of Real World Effectiveness Data and Safety in Patients Receiving Pazopanib With Advanced or Metastatic Renal Cell Carcinoma — Completed